Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Sendenhorst

7 clinical trials in Sendenhorst, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Sendenhorst at a glance
7
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Sendenhorst

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Tocilizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:AZD1163
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Tocilizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Secukinumab
  • Sponsor:Novartis Pharma GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Argenx
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Sendenhorst

What the registry says about research in the country

01 Inflammatory Vascular Disorders

Research focusing on Giant Cell Arteritis (GCA), evaluating innovative treatments for patients in clinical remission. Studies are investigating new therapeutic approaches to prevent disease relapse while reducing dependence on traditional glucocorticoid therapy.

  • Disease relapse prevention
  • Treatment optimization

Clinical trials aim to enhance long-term disease management strategies.

02 Muscle Inflammatory Conditions

Groundbreaking research on Idiopathic Inflammatory Myopathy (IIM), exploring novel therapeutic approaches. Studies evaluate advanced treatments in combination with standard immunomodulatory therapy to improve patient outcomes.

  • Clinical improvement assessment
  • Immunotherapy advancement

Focus on developing more effective treatment options for inflammatory muscle conditions.

03 Pediatric Rheumatology

Comprehensive studies of Juvenile Idiopathic Arthritis including its various subtypes. Research encompasses both pharmacokinetic evaluations and long-term safety assessments of innovative treatments for young patients.

  • Treatment safety in children
  • Long-term effectiveness
  • Specialized arthritis subtypes

Dedicated to improving therapeutic options for pediatric rheumatic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.